|
FDA Approves Label Change for Victoza Showing Superior Efficacy Over Januvia
The FDA has approved an update to the U.S. label for Novo Nordisk’s diabetes drug Victoza to include data showing superior blood sugar and weight control compared with Merck’s Januvia.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives